duloxetine / Generic mfg. |
ACTRN12624000919516: Duloxetine for chronic sciatica (DREAM): an adaptive randomised placebo-controlled trial |
|
|
| Not yet recruiting | 4 | 332 | | | The University of Sydney, National Health and Medical Research Council (NHMRC) | Sciatica | | | | |
| Ongoing | 4 | 100 | Europe | cymbalta, sipralexa, aspegic, Buccal tablet, Tablet, , cymbalta, sipralexa, aspegic | cliniques universitaire de mont godinne | major depression | | | | |
2014-005701-20: Het verschuiven van pijn modulatie naar pijnstilling: mechanisme-specifieke farmacologische preventie van post-sternotomie pijn: de MASTER studie |
|
|
| Ongoing | 4 | 300 | Europe | Capsule, Cymbalta, Lyrica | Leiden University Medical Center, LUMC | chronic pain chronische pijn, chronic pain chronische pijn, Body processes [G] - Physiological processes [G07] | | | | |
2005-003846-33: Efecto de la duloxetina en la respuesta nociceptiva cerebral en el trastorno depresivo mayor. Estudio mediante resonancia magnética funcional (RMf) |
|
|
| Ongoing | 4 | 72 | Europe | Duloxetina, Duloxetina (DCI), Cymbalta 30 mg cápsulas duras gastrorresistentes, Cymbalta 30 mg cápsulas duras gastrorresistentes | Dr. Narcís Cardoner | Trastorno depresivo mayor | | | | |
2008-005695-27: Comparing Problem Solving Treatment combined with duloxetine with Problem Solving Treatment alone for patients with major depressive disorder in primary care |
|
|
| Ongoing | 4 | 160 | Europe | duloxetine, Cymbalta, Cymbalta, Cymbalta | Eli Lilly Nederland | Major depressive disorder (episode or recurrent), moderately severe as principal DSM-IV diagnosis. | | | | |
| Ongoing | 4 | 50 | Europe | Paroxetine, Amitriptyline, Clomipramine, Imipramine, Nortriptyline, escitalopram, Citalopram, Fluoxetine, Fluvoxamine, Sertraline, Duloxetine, venlafaxine, EU/1/04/296/002, Seroxat, Tryptizol, Anafranil, Imipramine, Nortrilen, Lexapro, Cipramil, prozac, Fevarin, Zoloft, Cymbalta, Efexor, Seroxat, Tryptizol, Anafranil, Imipramine, Nortrilen, Lexapro, Cipramil, prozac, Fevarin, Zoloft, Cymbalta, Efexor | Isala Klinieken | Pregnant women with psychiatric morbidity and an strong indication for using antidepressants | | | | |
2009-010188-18: Effectiveness of the treatment of depressive disorder and comorbid pain symptoms |
|
|
| Ongoing | 4 | 219 | Europe | duloxetine, Cymbalta, Cymbalta, Cymbalta | Eli Lilly Nederland, Eli Lilly Nederland BV, GGz Breburg, Arkin, GGz inGeest | Major depressive disorder (episode or recurrent), as principal DSM-IV diagnosis combined with (sub)chronic pain symptoms as defined bij score of >3 on BPI painlist for at least six weeks. | | | | |
2014-001550-42: Combined molecular and functional brain imaging (PET/MR) to predict treatment response to neuropharmacological treatment Kombinierte molekulare und funktionelle Bildgebung des Gehirns (PET/MR) zur Vorhersage des Therapieerfolgs von Neuropharmaka |
|
|
| Ongoing | 4 | 80 | Europe | Seropram, Cymbalta, Efectin, Cipralex, Seropram, Cymbalta, Efectin, Cipralex, Seropram, Cymbalta, Efectin | Medizinische Universität Wien, Medizinische Universität Wien | Major depressive disorder Depression | | | | |
ChiCTR1900027181: Efficacy and Safety of Doloxetine in the Treatment of Subacute Herpes Zoster Neuralgia |
|
|
| Completed | 4 | 43 | | duloxetine with Oral administration of gabapentin, pregabalin and Mecobalamin ;Oral administration of gabapentin, pregabalin and Mecobalamin | Fujian Provincial Geriatric Hospital; None, self-funding | Subacute Herpes Zoster Neuralgia | | | | |
| Active, not recruiting | 4 | 36 | Canada | Levomilnacipran, Fetzima, Duloxetine, Cymbalta, Placebos | University of Ottawa, Allergan | None (i.e. Healthy Volunteers) | 12/19 | 05/22 | | |
ChiCTR1900027004: Role of SERTRALINE (SSRI) Versus DULOXETINE (SSNRI) among depressed total knee arthroplasty candidates: a prospective, randomized, patient selective, double blind study |
|
|
| Not yet recruiting | 4 | 180 | | DULOXETINE ;SERTRALINE ;placebo | Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University; West China Hospital, Sichuan University, Ministry of Health Special Scientific Research Projects of China | Total knee arthroplasty | | | | |
ChiCTR1900027005: Compare the effect of DULOXETINE Versus SERTRALINE in THA patients with anxiety and depression: a prospective, randomized, double-blinded study |
|
|
| Recruiting | 4 | 180 | | DULOXETINE ;SERTRALINE ;placebo | West China Hospital, Sichuan University; West China Hospital, Sichuan University, Ministry of Health Special Scientific Research Projects of China | THA | | | | |
ChiCTR-RPC-17012990: Functional magnetic resonance study of brain network mechanism in persistent somatoform pain disorder |
|
|
| Recruiting | 4 | 80 | | duloxetine sustained-release capsules ;none | Department of Psychology, The affiliated Drum Tower hospital of Nanjing university medical school; The affiliated Drum Tower hospital of Nanjing university medical school, Nanjing General course of medical science and technology development | persistent somatoform pain disorder | | | | |
ChiCTR2000033606: The effect of duloxetine on pain and functional rehabilitation after total hip replacement: a randomized controlled trial. |
|
|
| Recruiting | 4 | 100 | | Duloxetine ;Placebo | West China Hospital of Sichuan University; West China Hospital of Sichuan University, Ministry of Health Special Scientific Research Projects of China | Total hip arthroplasty | | | | |
ChiCTR2000033910: The Effects of Duloxetine on Pain and Hip Function after Total Knee Arthroplasty: a Randomized Controlled Trial. |
|
|
| Recruiting | 4 | 100 | | Duloxetine ;Placebo | West China Hospital of Sichuan University; West China Hospital of Sichuan University, Ministry of Health Special Scientific Research Projects of China | Total knee arthroplasty | | | | |
ChiCTR2000033605: The Effects of Duloxetine on Pain and Emotional Function Following Total Hip Arthroplasty in Patients With Anxiety and Depression: a Randomized Controlled Trial |
|
|
| Recruiting | 4 | 100 | | Duloxetine ;Placebo | West China Hospital of Sichuan University; West China Hospital of Sichuan University, Ministry of Health Special Scientific Research Projects of China | Total hip arthroplasty | | | | |
NCT04117893: Duloxetine Combined With Intra-articular Injection of Corticosteroid and Hyaluronic Acid Reduces Pain in the Treatment of Knee Osteoarthritis Patients |
|
|
| Completed | 4 | 150 | RoW | Duloxetine, intra-articular injection of corticosteroid and hyaluronic acid | Beijing Tiantan Hospital | Osteoarthritis, Knee, Chronic Pain | 06/21 | 12/21 | | |
ChiCTR2000033903: The Effects of Duloxetine on Pain and Emotional Function Following Total Knee Arthroplasty in Patients with Depression Symptoms: a Randomized Controlled Trial. |
|
|
| Recruiting | 4 | 100 | | Duloxetine 60 mg daily for 7 days, starting on the day of surgery (2 hours before surgery). ;Placebo 60 mg daily for 7 days, starting on the day of surgery (2 hours before surgery). | West China Hospital of Sichuan University; West China Hospital of Sichuan University, Ministry of Health Special Scientific Research Projects of China | Total knee arthroplasty | | | | |
ChiCTR2000030195: Duloxetine reduces postoperative pain and improves quality of life after single-segment lumbar fusion procedures in centrally sensitized patients: a prospective randomized controlled study |
|
|
| Recruiting | 4 | 100 | | duloxetine 60mg/day with standard analgesic regimen ;standard analgesic regimen | The Third People's Hospital of Chengdu; The Third People's Hospital of Chengdu, Self-financing | single-segment lumbar fusion | | | | |
ChiCTR2000035105: Duloxetine Reduces Pain and Improves Quality of Recovery Following the Repair of Rotator Cuff Injury |
|
|
| Recruiting | 4 | 120 | | duloxetine 30mg bid ;without duloxetine | West China Hospital of Sichuan University; West China Hospital of Sichuan University, 135 key fund of West China Hospital | Rotator cuff injury | | | | |
| Recruiting | 4 | 75 | RoW | Pregabalin, Duloxetine | Cairo University | Postoperative Pain | 08/21 | 09/21 | | |
ChiCTR1900027038: Synergistic Analgesia of Duloxetine in Phantom Limb Pain: a Randomized Controlled Trial. |
|
|
| Recruiting | 4 | 120 | | administration of duloxetine 60mg ;administration of placebo | Cancer Hospital of China Medical University; Cancer Hospital of China Medical University, self-financing | Phantom Limb Pain | | | | |
ChiCTR2100042981: Efficacy, safety and compliance of integrated traditional Chinese and Western medicine in patients with depression in the community: a multi-center, randomized controlled study |
|
|
| Not yet recruiting | 4 | 300 | | Use escitalopram or duloxetine ;Use Shu-Gan Jie-Yu capsule ;Use Shu-Gan Jie-Yu capsule combined with escitalopram or duloxetine | Shandong Mental Health Center; Shandong Mental Health Center, Shandong Province Integrated Traditional Chinese and Western Medicine Depression Prevention Project | Major depressive disorder | | | | |
ChiCTR2100047183: Investigation of the effect of duloxetine on the treatment of primary frozen shoulder |
|
|
| Recruiting | 4 | 102 | | Daily oral duloxetine 60mg ;Before treatment, 1 week, 2 week, 4 week, 8 week, 1 month after oral placebo or duloxetine | Tianjin Medical University General Hospital; Tianjin Medical University General Hospital, NSFC scientific research funds | Frozen shoulder | | | | |
ChiCTR2200056163: Effects of Pregabalin, Duloxetine and NSAIDs on Joint Pain and Function in Osteoarthritis Patients after Total Joint Arthroplasty |
|
|
| Not yet recruiting | 4 | 84 | | 200mg celecoxib b.i.d. (morning and night) p.o. for 4 weeks ;75mg pregabalin b.i.d. (morning and night) p.o. for 4 weeks ;30mg duloxetine b.i.d. (morning and night) p.o. for 4 weeks | West China Hopital of Sichuan University; West China Hopital of Sichuan University, 1.3.5 Project of West China Hospital [No. 2021YFQ0028] | Osteoarthritis | | | | |
ChiCTR2100046144: Combining multimodal magnetic resonance imaging and machine learning technology to explore the central mechanism of chronic primary frozen shoulder pain and the central analgesic mechanism of duloxetine |
|
|
| Recruiting | 4 | 60 | | Daily oral duloxetine 60mg | Tianjin Medical University General Hospital; Tianjin Medical University General Hospital, NSFC scientific research funds | Frozen shoulder | | | | |
ChiCTR2100054802: Effect of duloxetine administration in patients with depressive symptoms undergoing total knee arthroplasty: A randomized controlled trial |
|
|
| Recruiting | 4 | 70 | | Duloxetine 60 mg daily for 7 days, starting on the day of surgery (2 hours before surgery) ;Placebo 60 mg daily for 7 days, starting on the day of surgery (2 hours before surgery) | West China Hospital, Sichuan University; West China Hospital, Sichuan University, 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYJC18039) | Total knee arthroplasty | | | | |
ChiCTR2100054655: Effect of duloxetine administration in patients with depressive symptoms undergoing total hip arthroplasty: a randomized controlled trial |
|
|
| Not yet recruiting | 4 | 70 | | Duloxetine ;Placebo | West China Hospital, Sichuan University; West China Hospital, Sichuan University, 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYJC18039) | N/A | | | | |
2022-002780-30: Efficacy of patient education and duloxetine, alone and in combination, for patients with multiorgan bodily distress syndrome: a partial-factorial randomized controlled trial Patientundervisning og medicinsk behandling (duloxetin/aktiv placebo) til patienter med svær funktionel lidelse: et randomiseret, kontrolleret forsøg |
|
|
| Not yet recruiting | 4 | 212 | Europe | Cymbalta, Benztropine, Capsule, Tablet, Cymbalta, Benztropine | Aarhus University Hospital, The Research Clinic for Functional Disorders and Psychosomatics, The Tryg Foundation | Multiorgan Functional somatic disorders (FSD) / bodily disstress syndrome (BDS) multiorgan Funktionel lidelse, Functional somatic disorder Funktionel lidelse, Not possible to specify | | | | |
NCT05558397: Epidural Association of Morphine and Ropivacaine for Cancer Pain Treatment |
|
|
| Recruiting | 4 | 30 | RoW | Interventional Group (Epidural morphine), Control Group (Oral morphine) | Universidade Federal de Alfenas, Fundação de Amparo à Pesquisa do estado de Minas Gerais | Cancer Pain, Opioid Use, Cost Analysis, Palliative Care, Epidural Route, Morphine-ropivacaine Association, Quality of Life, Rational Use of Medication | 12/22 | 08/23 | | |
NCT05510856: Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients |
|
|
| Completed | 4 | 93 | RoW | Duloxetine, Gabapentin, Lacosamide | Tanta University | Oncology | 09/24 | 10/24 | | |
ChiCTR2100054831: Clinical efficacy and safety of duloxetine hydrochloride and amitriptyline combined with pregabalin in patients with herpes zoster neuralgia |
|
|
| Recruiting | 4 | 80 | | Duloxetine combined with pregabalin ;Amitriptyline combined with pregabalin | Nanjing Drum Tower Hospital, School of Medicine, Nanjing University; Nanjing Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing Drum Tower Hospital, School of Medicine, Nanjing University | Herpes zoster neuralgia | | | | |
| Recruiting | 4 | 40 | US | Scrambler Therapy, Calmare Therapy, Standard Medication Management | Johns Hopkins University | Post Stroke Pain | 12/25 | 12/25 | | |
| Recruiting | 4 | 504 | US | Duloxetine, Placebos | Rush University Medical Center | Pain, Postoperative, Total Knee Arthroplasty | 02/25 | 04/25 | | |
EDULOX, NCT06232473: Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder |
|
|
| Recruiting | 4 | 424 | Europe | Patient Education, Duloxetine, Cymbalta, SNRI, Benztropine Mesylate 0.5 MG and passive placebo RAP, Enhanced usual care | Aarhus University Hospital, Central Denmark Region, University of Aarhus, Vejle Hospital, Aalborg University Hospital, TrygFonden, Denmark, Independent Research Fund Denmark | Functional Disorder | 11/27 | 11/29 | | |
PREDICT, NCT06245109: Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis |
|
|
| Recruiting | 4 | 180 | US | Duloxetine, Cymbalta, Celecoxib, Celebrex, Placebo | Northwestern University, Brigham and Women's Hospital | Knee Osteoarthritis | 03/28 | 03/28 | | |
| Active, not recruiting | 4 | 1014 | US | Enhanced Self-Care (ESC), Acceptance and Commitment Therapy (ACT), Evidence-Based Exercise and Manual Therapy (EBEM), Duloxetine, Cymbalta | University of North Carolina, Chapel Hill, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Chronic Low-back Pain | 11/24 | 11/24 | | |
NCT06087211: Pain Relieving Potentials of Combination of Oral Duloxetine and Intravenous Magnesium Sulphate in Post Mastectomy Pain |
|
|
| Recruiting | 4 | 90 | RoW | Duloxetine and magnesium sulphate, cymbalta and magnesium sulphate, Duloxetine, cymbalta, placebo, control | National Cancer Institute, Egypt | Post-mastectomy Pain Syndrome | 04/24 | 04/24 | | |
RELIFE, NCT06423716: Effect of peRiopErative duLoxetIne Administration on Opioid Consumption Following Total kneE Arthroplasty |
|
|
| Not yet recruiting | 4 | 150 | Canada | Duloxetine, Placebo | Sunnybrook Health Sciences Centre | Knee Osteoarthritis | 07/26 | 12/26 | | |
| Completed | 4 | 345 | US | duloxetine, Irenka, Cymbalta, Web-based Cognitive Behavioral Therapy (CBT), Nurse-delivered Motivational Interviewing | Wake Forest University Health Sciences, National Institute of Nursing Research (NINR) | Chronic Pain | 07/24 | 07/24 | | |
| Recruiting | 4 | 60 | US | Duloxetine, Cymbalta, Irenka, Escitalopram, Lexapro | University of Cincinnati | Anxiety, Depressive Symptoms | 07/25 | 08/25 | | |
| Recruiting | 4 | 84 | US | Escitalopram, Lexapro, Duloxetine, Cymbalta | University of Cincinnati | Anxious Depression, Depression | 07/25 | 12/25 | | |
ChiCTR2400079841: Analysis of the efficacy of duloxetine and pregabalin for analgesia after total knee arthroplasty: a prospective, randomized controlled study |
|
|
| Not yet recruiting | 4 | 120 | | Oral duloxetine 60 mg/dose once daily beginning two days before surgery and continuing through 14 days postoperatively; Oral pregabalin 150 mg/dose twice daily beginning two days before surgery and continuing through 14 days postoperatively; Oral duloxetine 60 mg/dose once a day and oral pregabalin 150 mg/dose twice a day starting two days prior to surgery and continuing until 14 days postoperatively; After the 6h postoperative fasting period, oral erixib tablets 0.1g, codeine 500mg, starting on the second postoperative day and up to 14 days postoperatively, oral erixib tablets 0.1g/dose, 2 times/day, oral codeine 500mg/dose, 2 times/day | Honghui Hospital, Xi'an Jiaotong University; Honghui Hospital, Xi'an Jiaotong University, self-finance | osteoarthritis of the knee | | | | |
ChiCTR2400087090: A randomized double-blind multicenter psychiatric imaging study of Jiuwei Zhenxin granules in the treatment of patients with generalized anxiety disorder |
|
|
| Not yet recruiting | 4 | 100 | | Duloxetine (60mg qd) + Jiuwei Zhenxin granules placebo; Jiuwei Zhenxin granules (6g tid) + Duloxetine placebo; None | West China Hospital of Sichuan University; West China Hospital of Sichuan University, BEIJING BEILU PHARMACEUTICAL CO.,LTD | generalized anxiety disorder (GAD) | | | | |
SNRI, NCT05851898: Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures |
|
|
| Recruiting | 4 | 100 | US | Duloxetine 30 mg, Common brands: Irenka, Cymbalta | Wake Forest University Health Sciences | Depression in Old Age, Fragility Fracture | 02/25 | 02/25 | | |
NCT03548454: Comparing Effectiveness of Duloxetine and Desipramine in Patients With Chronic Pain: A Pragmatic Trial Using Point of Care Randomization |
|
|
| Recruiting | 4 | 320 | US | Duloxetine, Cymbalta, Desipramine, Norpramin | Stanford University | Chronic Pain | 07/25 | 07/25 | | |
NCT02670161: Quality Improvement and Practice Based Research in Neurology Using the EMR |
|
|
| Enrolling by invitation | 4 | 3300 | US | Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description), (too many characters to list in this field; see Intervention Description) | NorthShore University HealthSystem | Brain Tumors, Epilepsy, Migraine, Mild Cognitive Impairment, Concussion, Multiple Sclerosis, Neuropathy, Parkinson's, Restless Legs Syndrome, Stroke | 12/25 | 12/26 | | |
NCT05976347: Identifying and Treating Depression in the Orthopaedic Trauma Population |
|
|
| Not yet recruiting | 4 | 100 | US | Fluoxetine 20 MG, Prozac Weekly, Sarafem, Prozac, Duloxetine 30 MG, Irenka and Cymbalta, Observation, Referral to behavioral health and resources | Wake Forest University Health Sciences | Depression | 02/26 | 02/26 | | |
| Not yet recruiting | 4 | 800 | | Escitalopram oxalate; Paroxetine; Sertraline; Duloxetine; Mirtazapine; Shugan Jieyu capsule | Peking Union Medical College Hospital, Chinese Academy of Medical Sciences; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Project of National Key R&D Program of China (2022YFC2504004) | irritable bowel syndrome | | | | |
TD-AIDD, NCT06107829: Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities |
|
|
| Withdrawn | 4 | 25 | US | Valbenazine Oral Capsule, Ingrezza | Stephen Ruedrich, Neurocrine Biosciences | Tardive Dyskinesia, Intellectual Disability, Developmental Disabilities | 01/27 | 02/27 | | |
| Recruiting | 4 | 120 | US | Naproxen, Duloxetine | Montefiore Medical Center | Back Pain, Low | 05/26 | 05/26 | | |
NCT05737511: Efficacy of Hydroxyzine for Patients With Panic Disorder |
|
|
| Not yet recruiting | 4 | 80 | NA | Hydroxyzine, Atarax, Vistaril, Escitalopram Oxalate, citalopram, fluoxetine, fluvoxamine, paroxetine, paroxetine CR, sertraline, venlafaxine XR,, Alprazolam, clomipramine, clonazepam, diazepam, imipramine, lorazepam, mirtazapine, reboxetine, Bupropion SR, divalproex, duloxetine, gabapentin, levetiracetam, milnacipran, moclobemide, olanzapine, phenelzine, quetiapine, risperidone, tranylcypromine | Sultan Qaboos University | Panic Disorder | 12/26 | 12/26 | | |
ChiCTR2400081990: Duloxetine and pregabalin: High-dose monotherapy or their combination? -A prospective, randomised, triple-blind, parallel-group study of patients with postoperative pain after TKA based on the classification of Central Sensitization Inventory scores |
|
|
| Not yet recruiting | 4 | 1200 | | All received 200 mg celecoxib as prophylactic pain control 2 hours before surgery, and all were given 1 mL of a 100-mL mixture containing 2,000 mg of fentanyl as needed after surgery using an intravenous patient-controlled anaesthesia (PCA) pump. After patients resumed oral intake, they were given 1 mg of oxycodone every 12 hours for 7 days, and 200 mg of celecoxib, 37.5 mg of tramadol, and 650 mg of acetaminophen every 12 hours for 6 weeks after surgry; During the initial 6-week treatment period, patients received 60 mg of duloxetine per day and thereafter, during the 6-week combination/high-dose treatment period, only non-responders (response rate assessed on the basis of a 30% reduction in mean 24-h pain on the BPI, or a score of 2) received 120 mg of duloxetine per day; During the initial 6-week treatment period, patients received 60 mg of duloxetine per day. Thereafter, during the 6-week combination/high-dose treatment period, only non-responders (response rate assessed on the basis of a 30% reduction in mean 24-h pain on the BPI or a score of 2) received the combination of 60 mg duloxetine daily and 300 mg pregabalin daily; During the initial 6-week treatment period, patients received 300 mg of pregabalin daily. Thereafter, during the 6-week combination/high-dose treatment period, only non-responders (response rate assessed on the basis of a 30% reduction in mean 24-h pain on the BPI or a score of 2) received the combination of 60 mg duloxetine daily and 300 mg pregabalin daily; During the initial 6-week treatment period, patients received 300 mg of pregabalin per day. Thereafter, during the 6-week combination/high-dose treatment period, only non-responders (response rate assessed on the basis of a 30 per cent reduction in mean 24-h pain on the BPI or a score of 2) received 600 mg of pregabalin per day; All received 200 mg celecoxib as prophylactic pain control 2 hours before surgery, and all were given 1 mL of a 100-mL mixture containing 2,000 mg of fentanyl as needed after surgery using an intravenous patient-controlled anaesthesia (PCA) pump. After patients resumed oral intake, they were given 1 mg of oxycodone every 12 hours for 7 days, and 200 mg of celecoxib, 37.5 mg of tramadol, and 650 mg of acetaminophen every 12 hours for 6 weeks after surgry | Honghui Hospital, Xi'an Jiaotong University; Honghui Hospital, Xi'an Jiaotong University, self-finance | osteoarthritis of the knee | | | | |
| Active, not recruiting | 4 | 494 | US | PainGuide, MBSR, PT and exercise, Self -administered acupressure, Duloxetine, Cymbalta, Pro-Diary monitor, Electronic wrist device that looks like a watch | University of Michigan, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Chronic Low-back Pain | 06/27 | 06/27 | | |
ACTRN12619001082190: Serotonin Noradrenaline Reuptake Inhibitors (SNRI) medications for the treatment of osteoarthritis pain (STOP) trial |
|
|
| Recruiting | 3/4 | 146 | | | Waitemata District Health Board, Health Research Council of New Zealand | Knee osteoarthritis | | | | |
| Not yet recruiting | 3 | 160 | | | University of Technology Sydney, NHMRC | Neuropathic Cancer Pain; Cancer | | | | |
| Recruiting | 3 | 84 | | | University of Technology Sydney, NHMRC | Neuropathic Cancer Pain, Cancer | | | | |
2013-004313-41: Effect of pre-operative pain treatment on postoperative outcome after total hip or knee replacement surgery Effecten van pre-operatieve pijnbehandeling op postoperatieve uitkomsten na totale heup- of knievervanging |
|
|
| Ongoing | 3 | 118 | Europe | Gastro-resistant capsule, hard, Cymbalta | UMCG, Stichting ARGON (reumafonds "Dutch Arthritis Foundation") | Osteoarthritis (knee or hip) Artrose (knie of heup), degenerative joint disease (knee or hip) gewrichtsslijtage (knie of heup), Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2004-001237-42: Open-Label Duloxetine Extension phase in Patients Who Have Completed the F1J-MC-HMDG Clinical TrialFase de extensión abierta con duloxetina en aquellos pacientes que hayan finalizado el ensayo clínico F1J-MC-HMDG |
|
|
| Ongoing | 3 | 150 | Europe | Duloxetine Hydrochloride, LY248686, | Lilly S.A. | Major Depressive Disorder | | | | |
2008-000968-16: EFFICACY OF DULOXETINE IN THE TREATMENT OF URINARY INCONTINENCEAFTER PROSTATECTOMIE DUE TO CANCER |
|
|
| Ongoing | 3 | 90 | Europe | duloxetine, duloxetine, YENTREVE, YENTREVE | CeRePP | We want to evaluate the effect of Duloxetine 40mg BID (80mg daily dose) on the number of urinary incontinence episodes as shown on a 74 days bladder diary, compared to placebo for male which had a prostatectomy due to cancer. We\'ll also study tolerance and efficacy of duloxetine with Qol questionnaires. | | | | |
2010-018650-12: Evaluation du système noradrénergique dans l’altération de la perception douloureuse chez le patient Parkinsonien |
|
|
| Ongoing | 3 | 36 | Europe | duloxetine, apomorphine, levodopa, dompéridone, CYMBALTA, APOKINON, MODOPAR, MOTILIUM, CYMBALTA, APOKINON, MODOPAR, MOTILIUM | CHU de Toulouse | maladie de Parkinson | | | | |
2015-001669-16: Duloxetine for chronic osteoarthritis pain; an important alternative? Duloxetine voor chronische pijn bij artrose; is het een belangrijk alternatief? |
|
|
| Ongoing | 3 | 224 | Europe | Capsule, hard, Duloxetine | Erasmus MC, ZonMW | osteoarthritis artrose, osteoarthritis artrose, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2013-004881-33: Multicentre trial in to investigate the usage of antidepressant and antipsychotics (with / without approval) in patients at the age of children and adolescents Groß an gelegte, einfache offene klinische Studie mit mehreren teilnehmenden Prüfzentren zur Anwendung von Antidepressiva und Neuroleptika (mit /ohne Zulassung) |
|
|
| Ongoing | 3 | 1000 | Europe | Tablet, Abilify, Zyprexa, Leponex, Seroquel, Risperdal, Zeldox, Melneurin, Dipiperon, Saroten, Cipramil, Anafranil, Aponal, Cymbalta, Cipralex, Fluctin, Fevarin, Tofranil, Ludiomil, Remergil, Nortrilen, Paroxat, Zoloft, Stangyl, Trevilor | Universitätsklinikum Würzburg, Kompetenznetz TDM-KJP e.V., BfArM | therapeutic use in clinical practise Therapeutische Anwendung im klinischen Alltag, therapeutic use in clinical practise Therapeutische Anwendung im klinischen Alltag, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
2016-003146-89: Optimal pathway for treating neuropathic pain in diabetes mellitus. |
|
|
| Ongoing | 3 | 392 | Europe | Amitriptyline 25mg, Duloxetine, Pregabalin, Capsule, Gastro-resistant capsule, hard, , Amitriptyline 25mg, Duloxetine, Pregabalin 75mg | Sheffield Teaching Hospitals NHS Foundation Trust | Diabetic peripheral neuropathic pain., Painful nerve damage as a result of diabetes., Diseases [C] - Nervous System Diseases [C10] | | | | |
NCT03538691 / 2018-000601-22: A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder |
|
|
| Completed | 3 | 1149 | US | Brexpiprazole, OPC-34712, Rexulti, Antidepressant therapy | Otsuka Pharmaceutical Development & Commercialization, Inc. | Major Depressive Disorder | 07/22 | 07/22 | | |
| Withdrawn | 3 | 80 | US | Duloxetine, Cymbalta, Placebo | University of Utah | Major Depressive Disorder | 05/23 | 05/23 | | |
NCT06025474: Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome |
|
|
| Recruiting | 3 | 203 | Europe | Vortioxetine 20Mg Tab, Brintellix, Paroxetine 20 Mg Oral Tablet, Sertraline 50 MG, Citalopram 20mg, Escitalopram 10mg, Duloxetine 60 MG, Pregabalin 75mg | Federico II University | Burning Mouth Syndrome | 10/23 | 07/24 | | |
SKOAP, NCT04504812: A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain |
|
|
| Active, not recruiting | 3 | 1800 | US | Duloxetine, Cymbalta, Intra-Articular Injection, Nerve Procedure with long acting blocks, Nerve Procedure with nerve ablation, Pain Coping Skills Training, Best Practices | Johns Hopkins University, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Knee Osteoarthritis | 03/25 | 03/25 | | |
GENDOLCAT3, NCT06606067: Duloxetine to Prevent Chronic Postsurgical Pain After Inguinal Hernia Repair in Patients at High Risk |
|
|
| Active, not recruiting | 3 | 294 | Europe | Duloxetine, Placebo | Parc de Salut Mar, Carlos III Health Institute | Chronic Post-surgical Pain | 07/26 | 12/26 | | |
NCT06407401: Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer |
|
|
| Not yet recruiting | 3 | 399 | NA | Duloxetine 60 MG, Furosemide 40 mg, Booklet for healthy behaviors | European Organisation for Research and Treatment of Cancer - EORTC | ER+ Breast Cancer, HER2-negative Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, Drug-Related Side Effects and Adverse Reactions, Musculoskeletal Pain | 04/28 | 11/28 | | |
NCT05677295: Therapeutic Efficacy in Women With Stress Urinary Incontinence |
|
|
| Recruiting | 3 | 90 | RoW | duloxetine, Imipramine | Far Eastern Memorial Hospital | Women With Stress Urinary Incontinence | 12/24 | 12/24 | | |
ENFORCE, NCT06715462: Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy |
|
|
| Not yet recruiting | 3 | 858 | RoW | N0750, Cymbalta®, Lyrica® | Eurofarma Laboratorios S.A. | Painful Diabetic Peripheral Neuropathy (PDPN) | 04/27 | 04/27 | | |
INTENSIFY, NCT05603104: Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure |
|
|
| Recruiting | 3 | 1254 | RoW | Clozapine, ATC code: N05AH02, Esketamine Nasal Product, ATC code: N06AB10, Escitalopram, Sertraline, ATC code: N06AB06, Venlafaxine, ATC code: N06AX16, Lithium, ATC code: N05AN01, Valproate acid, ATC code: N03AG01, Quetiapine, ATC code: N05AH04, Second-line Antidepressants, Second-line Antipsychotics, Ketamine Hydrochloride, N01AX03, Esketamine hydrochloride, N015X14 | Dr. Inge Winter, Universität Münster | Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression | 06/26 | 06/26 | | |
INTENSIFY BD, NCT05973786: The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. |
|
|
| Recruiting | 3 | 418 | Europe | Escitalopram, ATC code: N06AB10, Sertraline, ATC code: N06AB06, Venlafaxine, ATC code: N06AX16, Lithium, ATC code: N05AN01, Valproate acid, ATC code: N03AG01, Quetiapine, ATC code: N05AH04 | Dr. Inge Winter, Universität Münster | Bipolar Depression | 06/26 | 06/26 | | |
CAPNEUCHIM, NCT05840562: Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy |
|
|
| Recruiting | 3 | 274 | Europe | Capsaicin, Qutenza, Duloxetine, Cymbalta | Institut Cancerologie de l'Ouest, Grünenthal GmbH | Chemotherapy-induced Peripheral Neuropathy | 03/27 | 03/27 | | |
| Not yet recruiting | 2/3 | 50 | NA | methadone, metadol, duloxetine, cymbalta | University of British Columbia, British Columbia Cancer Agency | Chemotherapy-induced Peripheral Neuropathy | 02/26 | 02/26 | | |
NCT04137107: Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer |
|
|
| Active, not recruiting | 2/3 | 220 | US, RoW | Oxaliplatin, Duloxetine Hydrochloride, Duloxetine, Quality-of-Life Assessment, Questionnaire Administration, Placebo | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8 | 02/25 | 12/25 | | |
| Recruiting | 2/3 | 330 | US | Antidepressant, AD: aripiprazole, bupropion, duloxetine, escitalopram, mirtazapine, sertraline, venlafaxine, Enhanced Fear Avoidance Rehabilitation, EFAR | Ajay Wasan, MD, Msc, National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Brigham and Women's Hospital, Mayo Clinic | Chronic Low Back Pain, Negative Affectivity | 12/25 | 04/26 | | |
ACTRN12617000139370: The use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy |
|
|
| Recruiting | 2 | 48 | | | Prince of Wales Hospital , Cancer Institute NSW | Chemotherapy-induced peripheral neuropathy | | | | |
2020-001285-11: A Randomized, open label, Non-inferiority trial on the efficacy of Lacosamide versus Duloxetine in Patients with Chemotherapy-induced Polyneuropathy – A strategy trial |
|
|
| Ongoing | 2 | 100 | Europe | Duloxetine, Lacosamide, N06AX21, N03AX18, Capsule, Film-coated tablet, Cymbalta, Vimpat | Leiden University Medical Center, Leiden University Medical Center | Chemotherapy-induced polyneuropathy, Nerve pain after chemotherapy, Diseases [C] - Nervous System Diseases [C10] | | | | |
| Recruiting | 2 | 70 | RoW | Duloxetine, Pregablin | National Cancer Institute, Egypt | Drug Effect | 03/21 | 04/21 | | |
NCT05018013: Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression |
|
|
| Recruiting | 2 | 240 | RoW | Ammoxetine hydrochloride enteric-coated tablets, Ammoxetine, Duloxetine hydrochloride enteric-coated capsules, Duloxetine, Placebo to Ammoxetine, Placebo, Placebo to Duloxetine | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Major Depressive Disorder (MDD) | 08/22 | 12/22 | | |
NCT04437485: eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk |
|
|
| Completed | 2 | 46 | US | Good Days Ahead (GDA), Cognitive-Behavioral Therapy (CBT), Internet Psychotherapy, Problem Solving Treatment in Primary Care (PST-PC), Telephonic Psychotherapy, Antidepressant Medications, Bupropion, Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Active Control | Indiana University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Depression, Major Depressive Disorder, Dysthymic Disorder, Depressive Symptoms, Type 2 Diabetes, PreDiabetes, Insulin Resistance | 08/22 | 08/22 | | |
NCT05486026: Efficacy of Duloxetine Compared to NSIADs in Osteoarthritis of Knee |
|
|
| Completed | 2 | 200 | RoW | Duloxetine 30 MG, Cymbalta, Nonsteroidal Antiinflammatory Drug, NSAID | Hawler Medical University | Osteo Arthritis Knee | 12/22 | 01/23 | | |
MACS-2, NCT05120934: Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough |
|
|
| Recruiting | 2 | 25 | US | Amitriptyline 25 MG, Amitriptyline 50 MG, Duloxetine 30 MG, Duloxetine 60 MG, Placebo 30 MG, Placebo 60 MG | Mayo Clinic | Interstitial Lung Disease | 12/25 | 12/25 | | |
MACS-1, NCT05110144: Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough |
|
|
| Recruiting | 2 | 50 | US | Duloxetine 30 MG, Duloxetine 60 MG, Amitriptyline 25 MG, Amitriptyline 50 MG, Placebo 30 MG, Placebo 60 MG | Mayo Clinic | Refractory Chronic Cough | 12/25 | 12/25 | | |
NCT06259526: A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression |
|
|
| Recruiting | 2 | 260 | RoW | Placebo group, JS1-1-01 placebo pills; Duloxetine hydrochloride placebo capsules, JS1-1-01 low-dose group, JS1-1-01 pills; JS1-1-01 placebo pills; Duloxetine hydrochloride placebo capsules, JS1-1-01 pills; JS1-1-01 placebo pills, JS1-1-01 high-dose group, JS1-1-01 pills; Duloxetine hydrochloride placebo capsules, Active drug group, JS1-1-01 placebo pills; Duloxetine hydrochloride enteric coated capsule | Tasly Pharmaceutical Group Co., Ltd | Depression | 04/25 | 04/25 | | |
NCT04653337: Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression |
|
|
| Recruiting | 2 | 56 | RoW | Robot-assisted accelerated iTBS-1800 combined with serotonin-norepinephrine reuptake inhibitors(SNRIs), Robot-assisted accelerated iTBS-600 combined with serotonin-norepinephrine reuptake inhibitors(SNRIs), Sham accelerated iTBS combined with serotonin-norepinephrine reuptake inhibitors(SNRIs) | Xijing Hospital | Suicidal Ideation, Depression | 12/23 | 12/23 | | |
NCT04970121: Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy |
|
|
| Recruiting | 2 | 100 | RoW | Duloxetine, Chemotherapy containing taxanes | Yan Yang, MD, Ph.D | Chemotherapy-induced Peripheral Neuropathy, Pain, Solid Tumor | 07/25 | 12/25 | | |
NCT06551051: ADC-induced Neurotoxicity Treated With Duloxetine |
|
|
| Recruiting | 2 | 37 | RoW | duloxetine, duloxetine hydrochloride | Fudan University | Solid Tumour | 12/25 | 12/25 | | |
NCT04111627: Exercise Plus Duloxetine for Knee Osteoarthritis |
|
|
| Recruiting | 2 | 30 | US | Aerobic exercise, Duloxetine | University of Maryland, Baltimore, National Institute on Aging (NIA) | Knee Osteoarthritis, Depression | 06/25 | 12/25 | | |
NCT06091553: Comparison of the Efficacy and Safety of Duloxetine Augmented With Gabapentin and Duloxetine Augmented With Amitriptyline vs Duloxetine Alone in Chemotherapy -Induced Neuropathy |
|
|
| Recruiting | 2 | 160 | RoW | Duloxetine alone, Duloxetine augmented with gabapentin, Duloxetine augmented with amitriptyline (as combined therapy) | Beni-Suef University | Neuropathy in Cacer Patien | 09/24 | 12/24 | | |
CLIMB, NCT06591091: Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression |
|
|
| Not yet recruiting | 2 | 80 | NA | Clemastine Fumarate, Placebo | University of Illinois at Chicago, Cures Within Reach | Depression | 01/25 | 03/25 | | |
NCT06614322: SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy. |
|
|
| Not yet recruiting | 2 | 190 | US | Pregabalin, Duloxetine, Placebo | University of Rochester, Beth Israel Deaconess Medical Center | Painful Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain (DPN), Chemotherapy Induced Peripheral Neuropathy (CIPN), Idiopathic Peripheral Neuropathy | 06/28 | 06/28 | | |
NCT04560673: Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy |
|
|
| Recruiting | 2 | 380 | US | Duloxetine, Neurofeedback, EEG biofeedback, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | 12/25 | 12/25 | | |
STAMD, NCT05814640: Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD) |
|
|
| Recruiting | 1/2 | 520 | RoW | Fluoxetine, Sertraline, Vortioxetine, Duloxetine, Aripiprazole, Lithium Carbonate, Olanzapine, GCBT | First Affiliated Hospital of Chongqing Medical University, The Second Affiliated Hospital of Chongqing Medical University, Children's Hospital of Chongqing Medical University, Southwest Hospital, China, Central South University | Depression, Sequestra | 12/25 | 07/27 | | |
NCT05949229: The Effect of Preoperative Duloxetine on the Occurance of Postoperative Delirium in Patients Undergoing Cancer Surgery. |
|
|
| Not yet recruiting | 1/2 | 42 | RoW | Duloxetine 60 MG | Amira Hassan Ahmed Ali | Post Operative Delirium | 08/26 | 12/26 | | |
NCT05292066: Efficacy of Pregabalin Vs Duloxetine in Diabetic Peripheral Neuropathic Pain at Variable Dose |
|
|
| Not yet recruiting | 1 | 126 | NA | Duloxetine Tablets,, Cymbalta,, Pregabalin Tablets, Lyrica. | Aga Khan University | Diabetic Peripheral Neuropathic Pain | 12/22 | 12/22 | | |
NCT03623711: A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on Depression |
|
|
| Recruiting | 1 | 200 | RoW | Escitalopram, Lexapro, Duloxetine, cymbalta, Bupropion, bupropion hydrochloride tablets, Healthy control, placebo tablets | Yuqi Cheng | Major Depressive Disorder, Depression, Unipolar | 12/22 | 12/22 | | |
| Completed | 1 | 19 | US | Alcohol, Placebos, Duloxetine, Methylphenidate | Craig Rush, National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcohol Use Disorder | 03/23 | 03/23 | | |